Voyager Therapeutics, Inc.

Direct answer

Voyager Therapeutics, Inc. is publicly traded on NASDAQ under the ticker VYGR.

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis...

Can you invest in Voyager Therapeutics, Inc.?

Yes. Voyager Therapeutics, Inc. trades publicly on NASDAQ as VYGR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Voyager Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.